Dow Down 0.18% Nasdaq Up 0.39%

Novo Nordisk A/S (NVO)

-NYSE
45.39 Down 0.57(1.24%) Sep 2, 4:01PM EDT
|After Hours : 45.36 Down 0.03 (0.07%) Sep 2, 6:04PM EDT
Prev Close:45.96
Open:45.30
Bid:45.00 x 100
Ask:46.70 x 200
1y Target Est:49.37
Beta:1.04
Next Earnings Date:N/A
Day's Range:45.17 - 45.66
52wk Range:32.20 - 48.42
Volume:1,606,583
Avg Vol (3m):909,780
Market Cap:119.33B
P/E (ttm):26.12
EPS (ttm):1.74
Div & Yield:0.61 (1.30%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NVODown 1.24%119.33B
LLYUp 0.19%68.25B
PFEDown 0.44%185.53B
SNYUp 0.49%144.25B

Key Statistics

Forward P/E (1 yr):22.58
P/S (ttm):8.11
Ex-Dividend Date:21-Mar-14

Analysts

Annual EPS Est (Dec-14) :1.80
Quarterly EPS Est (Jun-14) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):2.13

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback